Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Factor X
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Structure == {{See also|Factor IX#Domain architecture}} The first crystal structure of human factor Xa was deposited in May 1993. To date, 191 crystal structures of factor Xa with various inhibitors have been deposited in the protein data bank. The active site of factor Xa is divided into four subpockets as S1, S2, S3 and S4. The S1 subpocket determines the major component of selectivity and binding. The S2 sub-pocket is small, shallow and not well defined. It merges with the S4 subpocket. The S3 sub-pocket is located on the rim of the S1 pocket and is quite exposed to solvent. The S4 sub-pocket has three ligand binding domains: the "hydrophobic box", the "cationic hole" and the water site. Factor Xa inhibitors generally bind in an L-shaped conformation, where one group of the ligand occupies the anionic S1 pocket lined by residues [[Aspartic acid|Asp]]189, [[Serine|Ser]]195, and [[Tyrosine|Tyr]]228, and another group of the ligand occupies the aromatic S4 pocket lined by residues Tyr99, [[Phenylalanine|Phe]]174, and Trp215. Typically, a fairly rigid linker group bridges these two interaction sites.<ref>{{Cite web |url=http://pharmaxchange.info/presentations/Direct%20FXa%20Inhibitors.html |title=Presentation on Direct Factor Xa Inhibitors |access-date=2010-04-08 |archive-url=https://web.archive.org/web/20160303184211/http://pharmaxchange.info/presentations/Direct%20FXa%20Inhibitors.html |archive-date=2016-03-03 |url-status=dead }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)